Discover 245 paid clinical trials in Spokane, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 245
FeaturedActive & Responsive
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
for
Geographic Atrophy
Location: Spokane WA, Reno NV, Sacramento CA, San Francisco CA,
Sponsor: Genentech, Inc.
Sex: All
Age: 50+
Code: NCT05626114
Phase2, Recruiting
Featured
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
for
Neovascular Age-related Macular Degeneration
Location: Spokane WA, Salt Lake City UT, Reno NV, Sacramento CA,
Sponsor: Genentech, Inc.
Sex: All
Age: 50+
Code: NCT04853251
Recruiting
Active & Responsive
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
for
Cervical Dystonia
Location: Spokane WA, Fountain Valley CA, Farmington Hills MI,
Sponsor: Ipsen
Sex: All
Age: 18 - 70+
Code: NCT06937931
Phase2, Recruiting
Active & Responsive
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
for
Age-Related Macular Degeneration
Location: Spokane WA, Palo Alto CA, Los Angeles CA, Riverside CA,
Sponsor: Astellas Institute for Regenerative Medicine
Sex: All
Age: 50+
Code: NCT03178149
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Location: Spokane WA, Seattle WA, Kansas City KS, Kansas City MO,
Sponsor: University of Michigan
Sex: All
Age: 1 - 70+
Code: NCT04571658
Recruiting
Active & Responsive
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
for
Platinum-resistant Ovarian Cancer,
Location: Spokane WA, Reno NV, Las Vegas NV, Duarte CA, Orange CA,
Sponsor: Genelux Corporation
Sex: Female
Age: 18+
Code: NCT05281471
Phase3, Recruiting
Active & Responsive
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females